Change search
ReferencesLink to record
Permanent link

Direct link
Results of a multicenter randomized study to evaluate the safety and efficacy of combined immunotherapy with interleukin-2, interferon-alpha2b and histamine dihydrochloride versus dacarbazine in patients with stage IV melanoma.
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology. Onkologi.
Show others and affiliations
2007 (English)In: Annals of Oncology, ISSN 0923-7534, Vol. 18, no 10, 1691-1697 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2007. Vol. 18, no 10, 1691-1697 p.
Keyword [en]
clinical trials, dacarbazine, histamine dihydrochloride, immunotherapy, interferon alpha, interleukin-2, melanoma, phase III
URN: urn:nbn:se:umu:diva-16741DOI: doi:10.1093/annonc/mdm331OAI: diva2:156414
Available from: 2008-10-06 Created: 2008-10-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Naredi, Peter
By organisation

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 20 hits
ReferencesLink to record
Permanent link

Direct link